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Background: X-linked myopathy with postural muscle atrophy (XMPMA) is a novel X-linked myopathy caused by mutations in the Four-and-a-Half 
LIM Domain 1 gene (FHL1). As inheritance is X-linked, males are more severely affected and frequently develop hypertrophic cardiomyopathy and 
cardiac arrhythmias. We examined the correlation of FHL1 genotype with cardiac phenotype for clinical and prognostic implications.
Methods and Results: Seventeen male XMPMA patients, hemizygous for FHL1 mutations, and 23 XMPMA-negative female first-degree 
relatives, heterozygous for FHL1 mutations, were compared with 22 healthy age-matched male and 23 female family members without mutations. 
Every patient underwent a comprehensive clinical and cardiovascular workup. ECG abnormalities were more frequent in affected males than in 
heterozygous females. Myocardial mass was increased in both affected male (115.1±25.3g/m2) and heterozygous female mutation carriers 
(95.1±19.6g/m2), with increased wall thickness mainly in affected males (typically seen in midventricular and apical segments). Similar numbers 
of affected males and heterozygous females presented with diastolic dysfunction, but longitudinal systolic function assessed by systolic strain 
rate was reduced only in affected males (septal strain rate -0.70±0.35s-1 vs. -1.09±0.36s-1 in healthy males, p=0.008). Cardiac MRI revealed 
a morphological hallmark of XMPMA: All wall segments of the left ventricle including the apex of most affected males showed a characteristic 
spongious structure. More than half of affected males showed replacement fibrosis, and reduced exercise capacity was prevalent in all affected 
males (130±39watt).
Conclusions: XMPMA patients consistently showed cardiac abnormalities reflected in subclinical reduced exercise capacity, changes in 
morphology with a spongious hypertrophic structure associated with fibrosis and reduced systolic and diastolic function. An unexpected finding was 
that some cardiac abnormalities were also present in heterozygous female mutation carriers.
